|
1
|
Davel AP, Wenceslau CF, Akamine EH, Xavier
FE, Couto GK, Oliveira HT and Rossoni LV: Endothelial dysfunction
in cardiovascular and endocrine.metabolic diseases: An update. Braz
J Med Biol Res. 44:920–932. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Milan A, Tosello F, Fabbri A, Vairo A,
Leone D, Chiarlo M, Covella M and Veglio F: Arterial stiffness:
From physiology to clinical implications. High Blood Press
Cardiovasc Prev. 18:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Christen AI, Armentano RL, Miranda A, et
al: Arterial wall structure and dynamics in type 2 diabetes
mellitus methodological aspects and pathophysiological findings.
Curr Diabetes Rev. 6:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schram MT, Chaturvedi N, Fuller JH and
Stehouwer CD: EURODIAB Prospective Complications Study Group: Pulse
pressure is associated with age and cardiovascular disease in type
1 diabetes: The Eurodiab Prospective Complications Study. J
Hypertens. 21:2035–2044. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mangiapane H: Cardiovascular disease and
diabetes. Adv Exp Med Biol. 771:219–228. 2012.PubMed/NCBI
|
|
6
|
Sheikh-Ali M, Raheja P and Borja-Hart N:
Medical management and strategies to prevent coronary artery
disease in patients with type 2 diabetes mellitus. Postgrad Med.
125:17–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Janić M, Lunder M and Sabović M: A new
anti-ageing strategy focused on prevention of arterial ageing in
the middle-aged population. Med Hypotheses. 80:837–840. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Savić V, Eržen B, Janić M, Lunder M,
Boncelj M, Kanc K, Janež A and Šabović M: Improvement of arterial
wall characteristics by the low-dose fluvastatin and valsartan
combination in type 1 diabetes mellitus patients. Diab Vasc Dis
Res. 10:420–425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lunder M, Janić M, Jug B and Sabović M:
The effects of low-dose fluvastatin and valsartan combination on
arterial function: A randomized clinical trial. Eur J Intern Med.
23:261–266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Corretti MC, Anderson TJ, Benjamin EJ,
Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H,
Gerhard-Herman M, Herrington D, et al: Guidelines for the
ultrasound assessment of endothelial-dependent flow-mediated
vasodilation of the brachial artery: A report of the International
Brachial Artery Reactivity Task Force. J Am Coll Cardiol.
39:257–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Celermajer DS, Sorensen KE, Gooch VM,
Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK and Deanfield
JE: Non-invasive detection of endothelial dysfunction in children
and adults at risk of atherosclerosis. Lancet. 340:1111–1115. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cherney DZ and Montanari A: Gender,
clamped hyperglycemia and arterial stiffness in patients with
uncomplicated type 1 diabetes mellitus. Clin Exp Hypertens.
36:187–193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Llaurado G, Ceperuelo-Mallafre V,
Vilardell C, Simo R, Freixenet N, Vendrell J and Gonzalez-Clemente
JM: Arterial stiffness is increased in patients with type 1
diabetes without cardiovascular disease: A potential role of
low-grade inflammation. Diabetes Care. 35:1083–1089. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Elderen SG, Westenberg JJ, Brandts A,
van der Meer RW, Romijn JA, Smit JW and de Roos A: Increased aortic
stiffness measured by MRI in patients with type 1 diabetes mellitus
and relationship to renal function. AJR Am J Roentgenol.
196:697–701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pareyn A, Allegaert K, Asscherickx W,
Peirsman E, Verhamme P and Casteels K: Impaired endothelial
function in female adolescents with type 1 diabetes measured by
peripheral artery tonometry. Eur J Pediatr. 172:1017–1022. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanter JE and Bornfeldt KE: Inflammation
and diabetes-accelerated atherosclerosis: Myeloid cell mediators.
Trends Endocrinol Metab. 24:137–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Slim IB: Cardiovascular risk in type 1
diabetes mellitus. Indian J Endocrinol Metab. 17 (Suppl 1):S7–S13.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Snell-Bergeon JK and Nadeau K:
Cardiovascular disease risk in young people with type 1 diabetes. J
Cardiovasc Transl Res. 5:446–462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ben-Shlomo Y, Spears M, Boustred C, May M,
Anderson SG, Benjamin EJ, Boutouyrie P, Cameron J, Chen CH,
Cruickshank JK, et al: Aortic pulse wave velocity improves
cardiovascular event prediction: An individual participant
meta-analysis of prospective observational data from 17,635
subjects. J Am Coll Cardiol. 63:636–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ruggiero D, Paolillo S, Ratta GD,
Mariniello A, Formisano T, Pellegrino AM and Filardi PP:
Endothelial function as a marker of pre-clinical atherosclerosis:
Assessment techniques and clinical implications. Monaldi Arch Chest
Dis. 80:106–110. 2013.PubMed/NCBI
|
|
21
|
Lunder M, Drevenšek G, Černe D, Marc J,
Janić M and Šabović M: Treatment with low-dose atorvastatin,
losartan and their combination increases expression of
vasoactive-related genes in rat aortas. J Cardiovasc Pharmacol
Ther. 18:177–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Janic M, Lunder M, Prezelj M and Šabović
M: A combination of low-dose fluvastatin and valsartan decreases
inflammation and oxidative stress in apparently healthy middle-aged
males. J Cardiopulm Rehabil Prev. 34:208–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
